ASCO 2020 annual meeting
Programme du congrès
Lieu : Chicago, Illinois
Pays : Etats-Unis
Langue : ENG
Date de début :
Date de fin :
Spécialités : Oncologie
Cancer du sein : identification de biomarqueurs potentiels pour prédire lefficacité du ribociclib
- Date : 29/05/2020
- 6 0
Brian Jonas, ASCO20: Venetoclax combination treatment in older patients with acute myeloid leukemia
- Date : 29/05/2020
- 3 0
PART 1: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients
- Date : 29/05/2020
- 1 0
John Kuruvilla, ASCO20: Results of the KEYNOTE-204 Phase III Trial in Patients with cHL
- Date : 29/05/2020
- 1 0
PART 2: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients
- Date : 29/05/2020
- 1 0
ASCO Global Webinar Series: April 21, Laboratory Research & Screening Patients
- Date : 02/06/2020
- 1 0
MINDACT long-term results: 70-gene signature MammaPrint to guide adjuvant chemotherapy use
- Date : 29/05/2020
- 1 0
PANDA: Combining panitumumab with FOLFOX or 5FU in elderly patients with RAS-BRAF WT
- Date : 29/05/2020
- 1 0
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients
- Date : 29/05/2020
- 1 0
Cisplatin +/- veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer
- Date : 29/05/2020
- 1 0
Le programme CAPRI démontre l'efficacité du suivi à distance des traitements oraux
- Date : 29/05/2020
- 0 0
Résultats prometteurs d'une association de thérapies ciblées dans le gliome de l'enfant
- Date : 29/05/2020
- 0 0
ASCO Global Webinar Series July 28, Experiences and Lessons During the COVID-19 Pandemic
- Date : 28/06/2020
- 0 0
ASCO Global Webinar Series: June 30, Learning Through Collaboration -- Population-Based Research
- Date : 30/06/2020
- 0 0
ASCO Global Webinar Series: April 14, Experiences and Lessons During the COVID 19 Pandemic
- Date : 14/04/2020
- 0 0
ASCO Global Webinar Series: May 12, Practice Plans for Transitioning Back to Standard Operations
- Date : 12/04/2020
- 0 0
Perioperative novel systemic immunotherapy-based approaches in urinary cancers
- Date : 29/05/2020
- 0 0
COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected stage III BRAF
- Date : 29/05/2020
- 0 0
IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial cancer
- Date : 29/05/2020
- 0 0
FGFR inhibitors in bladder cancer: Testing, screening and highlights from ASCO 2020
- Date : 29/05/2020
- 0 0
High-dose twice daily thoracic radiotherapy in limited disease small-cell lung cancer
- Date : 29/05/2020
- 0 0
ASPEN: Results of a phase III randomised trial of zanubrutinib vs ibrutinib for patients
- Date : 29/05/2020
- 0 0
Reducing damage to swallowing muscles during radiotherapy for head and neck cancers
- Date : 29/05/2020
- 0 0
HCRN GU16-260: Nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients
- Date : 29/05/2020
- 0 0
PARP inhibitors in prostate cancer: Guidelines, who to test and the patient pathway
- Date : 29/05/2020
- 0 0
Early safety from a trial of talimogene laherparepvec (T-VEC) injected into liver tumours
- Date : 29/05/2020
- 0 0
3-weekly cisplatin or weekly cisplatin for squamous cell carcinoma of head and neck
- Date : 29/05/2020
- 0 0
US MM-6: Long-term proteasome inhibition in multiple myeloma following an in-class transition
- Date : 29/05/2020
- 0 0
Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based therapy for patients
- Date : 29/05/2020
- 0 0
Osimertinib plus gefitinib for treatment of EGFR-mutated non-small cell lung cancer
- Date : 29/05/2020
- 0 0
Comparing pevonedistat plus azacitidine versus azacitidine alone in patients with higher-risk
- Date : 29/05/2020
- 0 0
FORTE trial: Minimal residual disease evaluation in newly diagnosed multiple myeloma
- Date : 29/05/2020
- 0 0
Perioperative chemotherapy with mfolfirinox vs gemcitabine/nab-paclitaxel for resectable
- Date : 29/05/2020
- 0 0
CTC count as a prognostic marker for androgen deprivation plus orteronel or bicalutamide in mCSPC
- Date : 29/05/2020
- 0 0
TROPHIMMUN: Avelumab for gestational trophoblastic tumours resistant to monochemotherapy
- Date : 29/05/2020
- 0 0
KEYNOTE-177 results: Pembrolizumab versus chemotherapy for patients with MSI-H/dMMR colorectal
- Date : 29/05/2020
- 0 0
Timing of response to venetoclax combination treatment in older patients with acute myeloid
- Date : 29/05/2020
- 0 0
Venetoclax with bortezomib and dexamethasone in relapsed/refractory multiple myeloma
- Date : 29/05/2020
- 0 0
LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer progressing
- Date : 29/05/2020
- 0 0
Cumulative incidence of financial hardship in metastatic colorectal cancer patients
- Date : 29/05/2020
- 0 0
Association of BRCA alternations with response to PARP inhibitors in metastatic
- Date : 29/05/2020
- 0 0
COM701 as a monotherapy and in combination with nivolumab for various advanced solid tumours
- Date : 29/05/2020
- 0 0
Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma
- Date : 29/05/2020
- 0 0
E2108: Systemic therapy plus early local therapy versus systemic therapy alone
- Date : 29/05/2020
- 0 0
The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular
- Date : 29/05/2020
- 0 0
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chemotherapy
- Date : 29/05/2020
- 0 0
KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy
- Date : 29/05/2020
- 0 0
CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy
- Date : 29/05/2020
- 0 0
ASCO 2020: Pembrolizumab plus chemotherapy for patients with metastatic triple-negative
- Date : 29/05/2020
- 0 0
CANDOR trial design: Investigating KdD versus Kd in relapsed/refractory multiple myeloma
- Date : 29/05/2020
- 0 0
AGMT_MM-1: Investigating the oral microbiome in patients with relapsed/refractory multiple myeloma
- Date : 29/05/2020
- 0 0
Pembrolizumab vs brentuximab vedotin in relapsed or refractory classic Hodkin lymphomavvvv
- Date : 29/05/2020
- 0 0
KEYNOTE-427 updates: First-line pembrolizumab monotherapy in patients with advanced clear
- Date : 29/05/2020
- 0 0
Association of gene expression with clinical outcomes in advanced RCC patients treated
- Date : 29/05/2020
- 0 0
FRACTION-RCC: Evaluating nivolumab plus ipilimumab in patients with treatment-refractory
- Date : 29/05/2020
- 0 0
Sélection de congrès
14èmes Journées des Référentiels en Soins Oncologiques de support - AFSOS 2024
- Date : 12/12/2024
-
2197
0
45emes Journées de la Société Française de Sénologie et de Pathologie Mammaire - SFSPM 2024
- Date : 06/11/2024
-
4981
0